I50
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: For screening: nursing home resident in assigned nursing homes For clinical trial: nursing home resident with heart failure in assigned nursing homes
Exclusion criteria
Exclusion criteria: 1. A life expectancy less than 6 months for other reasons than HF, assessed by »surprise question« 2. Patients who will not sign informed consent or whose legal guardian will not sign informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The observed outcome for primary observed events will be the time to exacerbation of HF, defined as a need for intravenous diuretics or a need for emergency or out-of-hours intervention or a need for unplanned hospitalization for non-injury causes. | — |
Secondary
| Measure | Time frame |
|---|---|
| For secondary observed events, outcomes will be the time to whichever individual observed event, the change in quality of life and functional state after 6 months, number of days in hospital, out of hospital and death independent of the cause. | — |
Countries
Slovenia
Contacts
Faculty of Medicine, University of LjubljanaDepartment for family medicine